Acelrx Pharmaceuticals reported $13.27M in Cash and Equivalent for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 13.27M 13.06M
Baxter International BAX:US $ 3258M 122M
Becton, Dickinson and BDX:US $ 2283M 870M
Biodelivery Sciences International BDSI:US 100.71M 19.14M
Cara Therapeutics CARA:US $ 22.99M 656K
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Intra Cellular Therapies ITCI:US $ 106.13M 14.9M
Pain Therapeutics PTIE:US $ 241.52M 36.73M
Teva Pharmaceutical TEVA:IT 2.04B 391M
Xeris Pharmaceuticals Inc XERS:US $ 59.49M 4.11M
Zogenix ZGNX:US $ 106.14M 28.81M